Ninety One’s Edwards Lifesciences EW Stock Holding History

Ninety One’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$23M	Buy	265,013 +2,071	+0.8%	+$184K	1.15%	10
2026 Q2	$23.8M	Buy	262,942 +7,033	+3%	+$589K	1.29%	9
2026 Q1	$20.2M	Buy	255,909 +74,403	+41%	+$6.13M	0.87%	13
2025 Q4	$15.5M	Buy	181,506 +4,072	+2%	+$334K	0.67%	23
2025 Q3	$13.8M	Buy	177,434 +37,656	+27%	+$2.94M	0.62%	27
2025 Q2	$10.9M	Sell	139,778 -5,206	-4%	-$388K	1.79%	17
2025 Q1	$10.5M	Buy	144,984 +91,888	+173%	+$6.58M	1.94%	16
2024 Q4	$3.93M	Sell	53,096 -22,422	-30%	-$1.57M	0.87%	30
2024 Q3	$4.98M	Buy	75,518 +3,695	+5%	+$268K	1.09%	27
2024 Q2	$6.66M	Sell	71,823 -10,357	-13%	-$917K	1.03%	31
2024 Q1	$7.84M	Buy	82,180 +73,187	+814%	+$6.15M	1.13%	30
2023 Q4	$686K	Buy	+8,993	New	+$626K	0.1%	58

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return

BCAM

Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return

MIM

Manitou Investment Management Toronto, Ontario, Canada $532M AUM 7.98% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Ninety One's EW Position: Q3 2026 in Review

Ninety One increased its Edwards Lifesciences (EW) stake by 0.79% in Q3 2026, buying an estimated $184K and bringing the position to 265,013 shares worth $23M. The position accounts for 1.15% of the portfolio, ranked #10.

Ninety One first reported a position in EW in Q4 2023 and has held it in 12 quarters since. The position peaked at $23.8M in Q2 2026. 144 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Ninety One held 265,013 shares of Edwards Lifesciences worth $23M as of Q3 2026.
Ninety One bought 2,071 Edwards Lifesciences shares in Q3 2026, an estimated $184K.
Edwards Lifesciences made up 1.15% of Ninety One's portfolio in Q3 2026, its #10 holding.
Ninety One first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 12 quarters since.
Ninety One's Edwards Lifesciences position peaked at $23.8M in Q2 2026.
144 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Ninety One's 13F filing for Q3 2026, filed 15 Oct 2026.